The AstraZeneca rare disease group hopes to use these new gene therapy programs to bolster its work on genomic medicine.
As more novel therapy approvals trend towards biologics, it is important to take stock of what treatments are shaping the future of the market.
The new policy will require trading partners to supply, accept, and manage all documentation of product and ownership of prescription drugs electronically.
The updated vaccine will be ready to ship following a positive European Commission review.
This is the first biosimilar to Tysabri, an injection for adults with multiple sclerosis.
The patent grants Alterity 20 years of exclusivity over a new class of iron chaperone drug candidates.
The immunization, meant to protect infants aged six months or lower, is given to pregnant individuals at a gestation period of 32 to 36 weeks.
A major grant from the Bill & Melinda Gates Foundation will bolster efforts to fight the global HIV/AIDS epidemic.
Novartis has completed its acquisition of biopharma company Chinook Therapeutics.
The guidance can help both applicants and manufacturers limit the mutagenic and carcinogenic potential of NDSRIs.